STAT+: Medicare Part D spent twice what the VA paid for the same drugs
Medicare Part D spent more than twice as much on hundreds of prescription drugs than…
Author: STAT
STAT+: Drug makers sue HHS over a discount program serving low-income populations
In a clutch of lawsuits, three drug makers argue the federal government is wrong to…
STAT+: Pharmalittle: J&J Covid-19 vaccine data show some immunity after one dose; Biden may tap Sharfstein to run the FDA
Top of the morning to you, and a fine one it is. Despite the perennial…
STAT+: Former Merck employee arrested for stealing trade secrets on cancer research
A former Merck (MRK) cancer researcher was arrested and charged with stealing a raft of…
.jpg)
Vaccine registration technology is failing. Here’s how the Biden administration could fix it
The crashes of online vaccine scheduling systems have become a sad symbol of how technology…
STAT+: What comes after the telehealth boom? Hybrid care models are drawing investor interest
Buoyed by the pandemic, 2020 was undoubtedly the year that telehealth turned the corner to…
Opinion: Businesses across the supply chain must work together to make Covid-19 vaccines
As a scientist leading a company focused on RNA, I have cheered Pfizer, BioNTech, Moderna,…
.jpg)
Opinion: With Covid-19, ‘vaccine nationalism’ is a worrisome trend
Just after New Year’s Day, regulators in India granted authorization for restricted use to Bharat…
STAT+: ‘This is the foundation’: Health tech leaders discuss access, inequity, and community at CES
For all the focus on digital health at the Consumer Electronics Show for the past…
Watch: How — and why — coronaviruses mutate
Like all viruses, SARS-CoV-2, the virus that causes Covid-19, is mutating all the time. Recently…
Amid last minute changes and funding shortfalls, Biden adviser predicts a slow start to the ‘100 million vaccines in 100 days’ goal
WASHINGTON — President-elect Joe Biden is promising to administer 100 million doses of Covid-19 vaccine…
Covid-19 deaths are the highest they’ve ever been — and the more infectious variants could make things much worse
As horrific as the U.S. Covid-19 outbreak looks right now, it is almost certainly about…
Combination of two drugs can help treat methamphetamine addiction for some, new clinical trial data shows
As rates of methamphetamine overdose soar in the United States, one of the biggest challenges…
Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up
Johnson & Johnson published updated early data on its Covid-19 vaccine Wednesday, showing that it…
STAT+: Mark Cuban wades into the generic drug shark tank with a new company
Mark Cuban turns down new business opportunities on Shark Tank by declaring “I’m out!” But…
STAT+: 4 steps for AI developers to build trust in their clinical tools
As health systems deploy new tools that predict patients’ risk of serious medical outcomes, many…
Biden’s Covid-19 team reconsiders pandemic plan in light of more infectious coronavirus variants
WASHINGTON — President-elect Biden will address growing concerns about new, more transmissible coronavirus variants as…
Opinion: Using technology to help heal health care disparities
For the first time in its 54-year history, CES (formerly known as the Consumer Electronics…
Virtual Event: STAT@JPM: Facing 2021
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Sana Biotechnology, filing for IPO, aims for astronomical valuation
After years of rumors, Sana Biotechnology is positioning itself to file for an initial public…
Talkspace to go public in $1.4 billion SPAC deal
In a sign of the red-hot market for telemental health care, Talkspace announced Wednesday it…
STAT+: Pharmalittle: J&J Covid-19 vaccine production is behind schedule; Slaoui resigns from Operation Warp Speed
Rise and shine, everyone, the middle of the week is already here, which means we…
What if a pill could lower cholesterol like pricey injectables? Esperion intends to find out
The most powerful cholesterol drugs ever invented have become a pharmaceutical cautionary tale, failing to…
Opinion: Keep Covid-19 vaccination decisions out of the courtroom
Given the mounting frustration over the slow pace of vaccinations, yesterday’s HHS announcement broadening the…
U.S. plan to expand access to Covid-19 vaccine likely sets up new debacles
As health authorities across the country struggle to get Covid-19 vaccination programs up and running,…
STAT+: Health tech experts explain why trust is crucial for clinical AI tools
It was a slight departure from the usual Consumer Electronics Show panel: Rather than touting…
Opinion: ICE must provide Covid-19 vaccines to all detained migrants
After months of public health and political debates on vaccine prioritization for incarcerated populations, Covid-19…
STAT+: Endocrinologists urge federal lawmakers to act to lower insulin costs
Amid ongoing concerns over the cost of insulin, a leading physicians group is calling for…
STAT+: After repeated FDA rejections, key investor writes down stake in former diabetes unicorn Intarcia Therapeutics
Intarcia Therapeutics, a one-time biotech unicorn that has been unable to secure approval for a…
STAT+: STAT+ Conversations: The health tech news to watch at CES 2021
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. …
STAT+: Middlemen sue to block a signature Trump drug pricing proposal
WASHINGTON — The Pharmaceutical Care Management Association, which represents drug middlemen in Washington, filed a…
Scott Atlas, controversial former Trump adviser, deletes Twitter account
Scott Atlas, the radiologist who served for much of 2020 as President Trump’s most controversial…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production; HHS overrules FDA on its top lawyer pick
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT+: With durable monkey data, Verve selects its first CRISPR base editing treatment for human trials
Verve Therapeutics said Tuesday its one-time treatment that uses the “base editing” form of CRISPR…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019
During 2019, drug makers raised prices on seven widely used medicines by substantial amounts without…
Opinion: To make Covid-19 exposure apps work, integrate them with existing popular apps like Facebook
The beginning of the end of the Covid-19 pandemic may be at hand in the…
Opinion: Crossing the threshold: violence against home visiting nurses
It’s a difficult time to be a nurse. It’s an even more difficult time to…
Major health companies and trade groups suspend campaign contributions after Capitol riot
WASHINGTON — Following last week’s riot here, several major health care corporations are re-evaluating their…
STAT+: In a last-minute, intra-agency scuffle, HHS overrules FDA pick for a key position
WASHINGTON — Health secretary Alex Azar suddenly appointed a new top lawyer at the Food…
STAT+: Gilead’s remdesivir sales are surging, but investors aren’t impressed
A lot more Covid-19 patients in the U.S. are being treated with Gilead Sciences’ remdesivir…
STAT+: Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices
In a little-noticed move, a Commerce Department unit has proposed a new rule that would…
STAT+: A Covid-19 vaccine maker in India stirs controversy over its clinical trial
For the second time in two weeks, patient groups in India are raising concerns about…
STAT+: Lilly’s preliminary Alzheimer’s data adds $4 billion to Biogen’s value
Biogen added more than $4 billion in market value on Monday after a rival Alzheimer’s…
STAT+: Vertex Pharma taking more aggressive M&A stance, flush with cash from cystic fibrosis drugs
Vertex Pharmaceuticals is looking to acquire “mid- and late-stage assets” to bolster its current research…
Opinion: States and hospitals: overhaul your vaccine plans with data before it’s too late
The first phase of the vaccine rollout, which is supposed to deliver shots to roughly…
STAT+: Bluebird Bio intends to split into two companies, but for now, its troubles are also divided
Splitting Bluebird Bio into two publicly traded companies — one focused on cell therapies for…
STAT+: Pharmalittle: Lilly says Alzheimer’s drug may slow cognitive decline; half-dose of AstraZeneca Covid-19 shot may not work
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Tempus unveils prototype cube that talks back to oncologists
Tempus, a Chicago-based health technology company, wants oncologists to talk to the cube. The cube,…
STAT+: Company dedicated to cutting drug prices raises lots of money, releases few details
EQRx, a startup that made waves last year when it announced a plan to develop…
STAT+: Eli Lilly says drug slowed Alzheimer’s decline in preliminary study
An experimental medicine appeared to slow the decline of patients with the early symptoms of…